histori
develop
infecti
diseas
genom
tightli
associ
human
genom
project
hgp
watson
seri
import
discuss
hgp
made
dulbecco
watson
led
appoint
special
nation
research
council
nrc
committe
nation
academi
scienc
address
need
concern
impact
leadership
fund
sourc
committe
recommend
unit
state
begin
hgp
nrc
emphas
need
technolog
improv
effici
gene
map
sequenc
data
analysi
capabl
order
understand
potenti
function
human
gene
compar
sequenc
analys
also
advis
hgp
must
restrict
human
genom
includ
model
organ
includ
mous
bacteria
yeast
fruit
fli
worm
meantim
offic
technolog
assess
ota
us
congress
also
issu
similar
report
support
hgp
ota
depart
energi
doe
nation
institut
health
nih
jointli
present
initi
plan
hgp
dhh
doe
octob
sanger
centerinstitut
hinxton
uk
offici
open
join
hgp
cost
dna
sequenc
per
base
initi
aim
reduc
cost
less
per
base
largescal
sequenc
dhh
doe
sequenc
cost
gradual
declin
subsequ
year
nation
human
genom
research
institut
nhgri
challeng
scientist
achiev
human
genom
gbhaploid
genom
genom
meet
need
genom
medicin
first
complet
genom
sequenc
bacteriophag
kb
sanger
group
sanger
et
al
complet
genom
sequenc
polyomaviru
kb
publish
fier
et
al
reddi
et
al
human
viru
kb
genom
determin
baer
et
al
first
complet
freeliv
organ
genom
email
ytliu
ucsdedu
haemophilu
influenza
mb
sequenc
wholegenom
shotgun
approach
fleischmann
et
al
second
sequenc
bacteri
genom
mycoplasma
genitalium
kb
complet
less
month
year
use
approach
smith
doe
first
start
microbi
genom
program
mgp
companion
hgp
doe
initi
focu
nonpathogen
microb
along
develop
hgp
exponenti
growth
number
complet
sequenc
freeliv
organ
genom
fungal
genom
initi
fgi
fgi
establish
acceler
slow
pace
fungal
genom
sequenc
sinc
report
genom
saccharomyc
cerevisia
goffeau
et
al
one
major
interest
sequenc
organ
import
human
health
commerci
activ
septemb
complet
genom
project
increas
year
ago
document
liolio
et
al
includ
bacteri
archaeal
eukaryot
genom
addit
ongo
sequenc
project
report
genom
human
malaria
parasit
plasmodium
falciparum
major
mosquito
vector
anophel
gambia
publish
gardner
et
al
holt
et
al
effort
sequenc
malaria
genom
began
take
advantag
clone
deriv
laboratoryadapt
strain
hoffman
et
al
mani
parasit
complex
life
cycl
involv
vertebr
invertebr
host
difficult
maintain
laboratori
current
import
human
pathogen
parasit
trypansom
elsay
et
al
leishmania
iven
et
al
schistosoma
berriman
et
al
consortium
either
complet
partial
sequenc
brindley
et
al
aurrecoechea
et
al
meantim
genom
sequenc
aed
aegypti
primari
vector
yellow
fever
dengu
fever
publish
genom
size
mb
mosquito
vector
time
larger
previous
sequenc
genom
malaria
vector
anophel
gambia
approxim
genom
consist
transpos
element
genom
sequenc
bodi
lous
pediculu
humanu
humanu
obligatori
parasit
human
main
vector
epidem
typhu
rickettsia
prowazekii
relaps
fever
borrelia
recurrenti
trench
fever
bartonella
quintana
report
kirk
et
al
mb
genom
smallest
among
known
insect
genom
genom
sequenc
project
import
human
diseas
vector
progress
megi
et
al
includ
culex
pipien
mosquito
vector
west
nile
viru
ixod
scapulari
tick
vector
lyme
diseas
babesia
anaplasma
glossina
morsitan
tsets
fli
vector
african
trypanosomiasi
challeng
sequenc
genom
insect
vector
much
greater
microb
exampl
genom
tick
estim
gb
may
signific
proport
repetit
dna
sequenc
may
problem
genom
assembl
pagel
van
zee
et
al
furthermor
evolutionari
distanc
among
insect
speci
may
also
affect
homologybas
gene
predict
import
understand
sequenc
divers
within
speci
perform
de
novo
sequenc
refer
genom
perspect
human
health
true
host
pathogen
feero
et
al
alcai
et
al
goal
genom
project
find
genet
variant
frequenc
least
human
popul
studi
kaiser
one
similar
effort
human
pathogen
nih
influenza
genom
sequenc
project
project
began
novemb
seven
human
influenza
isol
complet
sequenc
deposit
genbank
databas
fauci
ghedin
et
al
may
human
avian
isol
complet
sequenc
includ
spanish
influenza
viru
taubenberg
et
al
databas
human
immunodefici
viru
hiv
hepat
c
viru
also
establish
human
studi
microb
focus
diseasecaus
organ
interest
resid
microorgan
also
grow
fact
estim
human
bodi
colon
least
time
prokaryot
eukaryot
microorgan
number
human
cell
savag
suggest
second
human
genom
project
sequenc
human
microbiom
relman
falkow
highli
variabl
intestin
microbi
flora
among
normal
individu
well
document
eckburg
et
al
costello
et
al
turnbaugh
et
al
therefor
human
microbiom
project
hmp
initi
nih
studi
sampl
multipl
bodi
site
least
normal
volunt
determin
whether
associ
chang
microbiom
sever
differ
medic
condit
provid
standard
data
resourc
new
technolog
approach
peterson
et
al
complet
ongo
genom
project
tabl
provid
enorm
opportun
discoveri
novel
vaccin
drug
target
human
pathogen
well
improv
diagnosi
discoveri
infecti
agent
develop
new
strategi
invertebr
vector
control
specif
exampl
provid
illustr
inform
provid
variou
genom
project
may
help
achiev
goal
promot
human
health
meningococc
isol
produc
antigen
distinct
capsular
polysaccharid
b
c
commonli
associ
diseas
lo
et
al
polysaccharid
capsul
import
meningococci
escap
complementmedi
kill
convent
vaccin
consist
conjug
capsular
polysaccharid
carrier
protein
meningococcu
serogroup
c
clinic
success
approach
fail
produc
clinic
use
vaccin
serogroup
b
menb
capsul
polysaccharid
nacetylneuramin
acid
menb
ident
human
polysial
acid
therefor
poorli
immunogen
finn
et
al
altern
vaccin
consist
outer
membran
vesicl
omv
success
develop
control
menb
outbreak
area
epidem
domin
one
particular
strain
bjune
et
al
sierra
et
al
boslego
et
al
jackson
et
al
signific
limit
type
vaccin
immun
respons
strainspecif
mostli
direct
porin
protein
pora
vari
substanti
express
level
sequenc
across
strain
martin
et
al
pizza
et
al
complet
genom
sequenc
virul
menb
strain
revers
vaccinolog
approach
appli
develop
univers
menb
vaccin
novarti
pizza
et
al
tettelin
et
al
giuliani
et
al
bioinformat
search
surfaceexpos
antigen
may
suitabl
vaccin
candid
due
potenti
readili
recogn
immun
system
open
read
frame
orf
select
total
orf
genom
eventu
five
antigen
chosen
vaccin
compon
base
seri
criteria
includ
abil
candid
express
escherichia
coli
recombin
protein
candid
confirm
surfac
exposur
immunolog
analys
abil
induc
protect
antibodi
experiment
anim
candid
conserv
antigen
within
panel
divers
meningococc
strain
primarili
diseaseassoci
menb
strain
pizza
et
al
giuliani
et
al
rinaudo
et
al
vaccin
formul
consist
fusion
protein
fusion
protein
nada
omv
new
zealand
menzb
vaccin
strain
contain
immunogen
pora
initi
phase
ii
clinic
result
adult
infant
show
vaccin
could
induc
protect
immun
respons
three
divers
menb
strain
subject
follow
three
vaccin
four
vaccin
rinaudo
et
al
phase
iii
trial
vaccin
met
primari
endpoint
target
essenti
pathway
necessari
suffici
requir
effect
antimicrobi
agent
brinster
et
al
identif
essenti
gene
complet
sequenc
genom
activ
pursu
variou
approach
hutchison
et
al
ji
et
al
indispens
fatti
acid
synthas
fa
pathway
bacteria
regard
promis
target
develop
antimicrobi
agent
wright
reynold
subcellular
organ
fatti
acid
biosynthesi
compon
differ
mammal
type
fa
bacteria
dissoci
type
ii
fa
rais
likelihood
host
specif
target
drug
comparison
avail
genom
sequenc
variou
speci
prokaryot
reveal
highli
conserv
fa
ii
system
suggest
antimicrobi
agent
broad
spectrum
zhang
et
al
addit
comput
analys
new
member
fa
ii
system
discov
differ
bacteri
speci
heath
rock
marrakchi
et
al
one
protein
compon
system
fabi
target
antituberculosi
drug
isoniazid
gener
antibacteri
antifung
agent
triclosan
banerje
et
al
levi
et
al
zhang
et
al
systemat
screen
natur
product
extract
merck
team
identifi
potent
broadspectrum
antibiot
platensimycin
deriv
streptomyc
platensi
select
fabfb
inhibitor
fa
ii
system
wang
et
al
treatment
platensimycin
erad
staphylococcu
aureu
infect
mice
platensimycin
crossresist
antibioticresist
strain
vitro
includ
methicillinresist
aureu
vancomycinintermedi
aureu
vancomycinresist
enterococci
toxic
observ
use
cultur
human
cell
line
activ
platensimycin
affect
presenc
human
serum
studi
howev
fa
ii
system
appear
dispens
anoth
gramposit
bacterium
streptococcu
agalactia
exogen
fatti
acid
avail
human
serum
brinster
et
al
baleman
et
al
suscept
inhibitor
target
fa
ii
system
indic
heterogen
fatti
acid
synthesi
acquir
exogen
fatti
acid
among
gramposit
pathogen
baleman
et
al
compar
genom
approach
may
use
identifi
develop
strategi
target
salvag
pathway
streptococcu
agalactia
altern
similar
approach
describ
earlier
menb
vaccin
may
also
appli
streptococcu
agalactia
group
b
streptococcu
maion
et
al
earli
mathemat
model
malaria
control
suggest
vulner
element
malaria
cycl
survivorship
adult
femal
mosquito
macdonald
enayati
hemingway
therefor
insect
control
import
part
reduc
transmiss
use
ddt
indoor
residu
spray
global
malaria
erad
program
reduc
popul
risk
malaria
compar
hay
et
al
enayati
hemingway
engin
genet
modifi
mosquito
refractori
malaria
infect
appear
altern
approach
curti
given
environment
impact
ddt
emerg
insecticideresist
insect
vector
biolog
network
vbn
form
propos
plan
world
health
organ
achiev
three
major
goal
develop
basic
tool
stabl
transform
anophelin
mosquito
year
engin
mosquito
incap
carri
malaria
parasit
run
control
experi
test
drive
engin
genotyp
wild
mosquito
popul
alphey
et
al
morel
et
al
beati
et
al
proofofconcept
experi
achiev
first
two
aim
anophel
gambia
genom
complet
sequenc
catteruccia
et
al
ito
et
al
progress
rel
slow
marshal
taylor
genom
loci
anophel
gambia
respons
plasmodium
falciparum
resist
identifi
survey
mosquito
popul
west
african
malaria
transmiss
zone
riehl
et
al
candid
gene
anophel
plasmodiumrespons
leucinerich
repeat
discov
subsequ
resist
gene
also
identifi
blandin
et
al
povelon
et
al
studi
genet
basi
resist
malaria
parasit
immun
mosquito
vector
import
control
malaria
transmiss
perhap
immedi
impact
complet
sequenc
pathogen
genom
infecti
diseas
diagnosi
inform
may
great
import
public
health
newli
emerg
reemerg
pathogen
discov
swineorigin
influenza
viru
soiv
dawood
et
al
sar
sever
acut
respiratori
syndrom
coronaviru
rota
et
al
two
recent
exampl
soiv
emerg
spring
mexico
also
discov
specimen
two
unrel
children
san
diego
area
april
cdc
dawood
et
al
sampl
posit
influenza
neg
human
subtyp
complet
genom
sequenc
realtim
pcrbase
diagnost
assay
releas
public
late
april
outbreak
evolv
rapidli
declar
highest
phase
worldwid
pandem
alert
june
soiv
three
genom
segment
ha
np
ns
classic
north
american
swine
lineag
two
segment
pa
north
american
avian
lineag
one
segment
season
notabl
two
segment
na
eurasian
swine
lineag
dawood
et
al
avail
influenza
genom
databas
diagnost
assay
distinguish
previou
season
soiv
easili
accomplish
lu
et
al
comprehens
pathogen
genom
databas
use
infecti
diseas
diagnosi
also
novel
pathogen
discoveri
liu
homolog
sequenc
within
famili
among
differ
famili
member
import
new
pathogen
identif
even
advent
thirdgener
sequenc
technolog
munro
harri
de
novo
pathogen
discoveri
may
also
complic
coexist
microorgan
commens
bacteria
human
bodi
without
prior
knowledg
microorgan
one
may
misl
microarraybas
assay
design
virochip
use
help
discov
sar
coronaviru
wang
et
al
virochip
contain
highli
conserv
sequenc
everi
fulli
sequenc
refer
viral
genom
genbank
comput
search
conserv
perform
across
known
viral
famili
microarray
hybrid
reaction
deriv
viral
isol
cultiv
sar
patient
reveal
strongest
hybrid
array
element
belong
famili
astrovirida
coronavirida
align
oligonucleotid
probe
highest
signal
show
four
hybrid
oligonucleotid
astrovirida
one
oligonucleotid
avian
infecti
bronchiti
viru
avian
coronaviru
share
core
consensu
motif
span
nucleotid
interestingli
known
previous
bioinformat
analys
sequenc
present
utr
astrovirus
avian
infecti
bronchiti
viru
equin
rhinoviru
jonassen
et
al
therefor
new
member
coronaviru
identifi
uniqu
hybrid
pattern
subsequ
confirm
find
seventh
human
oncogen
viru
merkel
cell
polyomaviru
mcv
feng
et
al
anoth
exampl
conserv
sequenc
import
novel
pathogen
discoveri
mcv
etiolog
agent
merkel
cell
carcinoma
mcc
rare
aggress
skin
cancer
neuroendocrin
origin
two
cdna
librari
deriv
mcc
tumor
subject
highthroughput
sequenc
nextgener
sequenc
nearli
sequenc
read
gener
major
sequenc
deriv
human
origin
remov
analys
one
remain
cdna
homolog
antigen
two
known
polyomavirus
one
addit
cdna
subsequ
identifi
part
mcv
sequenc
complet
viral
sequenc
known
later
analys
show
mcc
integr
mcv
human
genom
monoclon
viral
integr
reveal
pattern
southern
blot
analysi
control
tissu
low
copi
number
mcv
infect
expect
effort
varieti
genom
project
may
improv
human
health
socioeconom
issu
discuss
chapter
may
substanti
addit
tremend
amount
inform
deriv
project
also
challeng
scientist
well
nonscientist
follow
understand
